WallStreetZen

NYSE: MRK
Merck & Co Inc Stock Forecast, Predictions & Price Target

Analyst price target for MRK

Based on 5 analysts offering 12 month price targets for Merck & Co Inc.
Min Forecast
$88.00+8.44%
Avg Forecast
$95.60+17.81%
Max Forecast
$105.00+29.39%

Should I buy or sell MRK stock?

Based on 6 analysts offering ratings for Merck & Co Inc.
Buy
Strong Buy
3 analysts 50%
Buy
1 analysts 16.67%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

MRK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
SVB Leerink
Bottom 2%
2
BuyMaintains$105.00+29.39%2021-10-22
Morgan Stanley
Top 15%
86
HoldMaintains$88.00+8.44%2021-10-12
Anonymous
Berenberg
HoldMaintains$92.00+13.37%2021-10-11
Barclays
Bottom 17%
17
Strong BuyMaintains$92.00+13.37%2021-10-08
JP Morgan
Bottom 4%
4
Strong BuyMaintains$100.00+23.23%2021-06-09
Truist Securities
Top 25%
76
Strong BuyMaintains$93.00+14.60%2021-06-07
Argus Research
Top 30%
71
HoldDowngradesN/AN/A2021-05-20

1 of 1

Forecast return on equity

Is MRK forecast to generate an efficient return?
Company
56.8%
Industry
75.11%
Market
17.31%
MRK's Return on Equity is forecast to be high in 3 years (56.8%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is MRK forecast to generate an efficient return on assets?
Company
20.85%
Industry
16.47%
MRK is forecast to generate higher Return on Assets (20.85%) than the US Drug Manufacturers - General industry average (16.47%)
Forecast

MRK earnings per share forecast

What is MRK's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$5.51+150.45%
Avg 2 year Forecast
$6.28+185.45%
Avg 3 year Forecast
$6.76+207.27%
MRK's earnings are forecast to grow at an exceptional rate of 45.96% per year
Forecast

MRK revenue forecast

What is MRK's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$48.3B-0.61%
Avg 2 year Forecast
$53.2B+9.55%
Avg 3 year Forecast
$52.5B+8.13%
MRK's revenue is forecast to grow at a rate of 2.64% per year, which is not exceptional
Forecast

MRK earnings growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
45.96%
Industry
22.55%
Market
18.33%
MRK's earnings are forecast to grow faster (45.96% per year) than the US Drug Manufacturers - General industry average (22.55%)
Forecast
MRK's earnings are forecast to grow faster (45.96% per year) than the US market average (18.33%)
Forecast
MRK's earnings are forecast to grow faster (45.96% per year) than the risk-free savings rate (1.7%)
Forecast

MRK revenue growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
2.64%
Industry
4.66%
Market
11.75%
MRK's revenues are forecast to grow slower (2.64% per year) than the US Drug Manufacturers - General industry average (4.66%)
Forecast
MRK's revenues are forecast to grow slower (2.64% per year) than the US market average (11.75%)
Forecast

Merck & Stock Forecast FAQ

Is Merck & Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: MRK) stock is to Buy MRK stock.

Out of 6 analysts, 3 (50%) are recommending MRK as a Strong Buy, 1 (16.67%) are recommending MRK as a Buy, 2 (33.33%) are recommending MRK as a Hold, 0 (0%) are recommending MRK as a Sell, and 0 (0%) are recommending MRK as a Strong Sell.

What is MRK's earnings growth forecast for 2021-2023?

(NYSE: MRK) Merck &'s forecast annual earnings growth rate of 45.96% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 22.55%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 18.33%.

Merck &'s earnings in 2021 is $5,571,000,000.On average, 7 Wall Street analysts forecast MRK's earnings for 2021 to be $13,947,874,575, with the lowest MRK earnings forecast at $13,846,619,587, and the highest MRK earnings forecast at $14,049,129,563. On average, 8 Wall Street analysts forecast MRK's earnings for 2022 to be $15,897,033,091, with the lowest MRK earnings forecast at $15,390,758,152, and the highest MRK earnings forecast at $16,504,563,018.

In 2023, MRK is forecast to generate $17,112,092,945 in earnings, with the lowest earnings forecast at $15,821,091,850 and the highest earnings forecast at $18,327,152,799.

What is MRK's revenue growth forecast for 2021-2023?

(NYSE: MRK) Merck &'s forecast annual revenue growth rate of 2.64% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.75%.

Merck &'s revenue in 2021 is $48,548,000,000.On average, 4 Wall Street analysts forecast MRK's revenue for 2021 to be $122,142,251,500,589, with the lowest MRK revenue forecast at $116,640,683,242,288, and the highest MRK revenue forecast at $129,674,453,100,775. On average, 4 Wall Street analysts forecast MRK's revenue for 2022 to be $134,623,771,592,648, with the lowest MRK revenue forecast at $125,652,377,160,048, and the highest MRK revenue forecast at $147,406,125,316,328.

In 2023, MRK is forecast to generate $132,881,785,844,598 in revenue, with the lowest revenue forecast at $128,391,324,581,120 and the highest revenue forecast at $137,172,789,970,279.

What is MRK's forecast return on assets (ROA) for 2021-2024?

(NYSE: MRK) forecast ROA is 20.85%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.47%.

What is MRK's Price Target?

According to 5 Wall Street analysts that have issued a 1 year MRK price target, the average MRK price target is $95.60, with the highest MRK stock price forecast at $105.00 and the lowest MRK stock price forecast at $88.00.

On average, Wall Street analysts predict that Merck &'s share price could stay at $95.60 by Oct 22, 2022. The average Merck & stock price prediction forecasts a potential downside of N/A from the current MRK share price of $81.15.

What is MRK's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: MRK) Merck &'s current Earnings Per Share (EPS) is $2.20. On average, analysts forecast that MRK's EPS will be $5.51 for 2021, with the lowest EPS forecast at $5.47, and the highest EPS forecast at $5.55. On average, analysts forecast that MRK's EPS will be $6.28 for 2022, with the lowest EPS forecast at $6.08, and the highest EPS forecast at $6.52. In 2023, MRK's EPS is forecast to hit $6.76 (min: $6.25, max: $7.24).

What is MRK's forecast return on equity (ROE) for 2021-2024?

(NYSE: MRK) forecast ROE is 56.8%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.